Literature DB >> 19726882

Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I.

Martin Kruse1, Eric Schulze-Bahr, Valerie Corfield, Alf Beckmann, Birgit Stallmeyer, Güven Kurtbay, Iris Ohmert, Ellen Schulze-Bahr, Paul Brink, Olaf Pongs.   

Abstract

Progressive familial heart block type I (PFHBI) is a progressive cardiac bundle branch disease in the His-Purkinje system that exhibits autosomal-dominant inheritance. In 3 branches of a large South African Afrikaner pedigree with an autosomal-dominant form of PFHBI, we identified the mutation c.19G-->A in the transient receptor potential cation channel, subfamily M, member 4 gene (TRPM4) at chromosomal locus 19q13.3. This mutation predicted the amino acid substitution p.E7K in the TRPM4 amino terminus. TRPM4 encodes a Ca2+-activated nonselective cation (CAN) channel that belongs to the transient receptor potential melastatin ion channel family. Quantitative analysis of TRPM4 mRNA content in human cardiac tissue showed the highest expression level in Purkinje fibers. Cellular expression studies showed that the c.19G-->A missense mutation attenuated deSUMOylation of the TRPM4 channel. The resulting constitutive SUMOylation of the mutant TRPM4 channel impaired endocytosis and led to elevated TRPM4 channel density at the cell surface. Our data therefore revealed a gain-of-function mechanism underlying this type of familial heart block.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726882      PMCID: PMC2735920          DOI: 10.1172/JCI38292

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Internalization of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95.

Authors:  D G Jugloff; R Khanna; L C Schlichter; O T Jones
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

2.  The registry of the European Working Group on Cardiac Pacing (EWGCP). A working group of the European Society of Cardiology.

Authors:  H Ector; A F Rickards; L Kappenberger; P Vardas; A Oto; M Santini; R Sutton
Journal:  Europace       Date:  2000-07       Impact factor: 5.214

3.  Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.

Authors:  Darja Schmidt; Stefan Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

4.  Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease.

Authors:  Daniel Bailey; Peter O'Hare
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

Review 5.  Mutual interactions between the SUMO and ubiquitin systems: a plea of no contest.

Authors:  Helle D Ulrich
Journal:  Trends Cell Biol       Date:  2005-08-25       Impact factor: 20.808

Review 6.  Calcium-activated nonselective cation channels in mammalian cardiomyocytes.

Authors:  Romain Guinamard; Marie Demion; Aurélien Chatelier; Patrick Bois
Journal:  Trends Cardiovasc Med       Date:  2006-10       Impact factor: 6.677

7.  A sodium-channel mutation causes isolated cardiac conduction disease.

Authors:  H L Tan; M T Bink-Boelkens; C R Bezzina; P C Viswanathan; G C Beaufort-Krol; P J van Tintelen; M P van den Berg; A A Wilde; J R Balser
Journal:  Nature       Date:  2001-02-22       Impact factor: 49.962

8.  Novel gain-of-function mechanism in K(+) channel-related long-QT syndrome: altered gating and selectivity in the HERG1 N629D mutant.

Authors:  J P Lees-Miller; Y Duan; G Q Teng; K Thorstad; H J Duff
Journal:  Circ Res       Date:  2000-03-17       Impact factor: 17.367

9.  TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization.

Authors:  Pierre Launay; Andrea Fleig; Anne Laure Perraud; Andrew M Scharenberg; Reinhold Penner; Jean Pierre Kinet
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

10.  Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI).

Authors:  Soraya Bardien-Kruger; Heike Wulff; Zainu Arieff; Paul Brink; K George Chandy; Valerie Corfield
Journal:  Eur J Hum Genet       Date:  2002-01       Impact factor: 4.246

View more
  114 in total

1.  A connexin40 mutation associated with a malignant variant of progressive familial heart block type I.

Authors:  Naomasa Makita; Akiko Seki; Naokata Sumitomo; Halina Chkourko; Shigetomo Fukuhara; Hiroshi Watanabe; Wataru Shimizu; Connie R Bezzina; Can Hasdemir; Hideo Mugishima; Takeru Makiyama; Alban Baruteau; Estelle Baron; Minoru Horie; Nobuhisa Hagiwara; Arthur A M Wilde; Vincent Probst; Hervé Le Marec; Dan M Roden; Naoki Mochizuki; Jean-Jacques Schott; Mario Delmar
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

Review 2.  TRPM channels: same ballpark, different players, and different rules in immunogenetics.

Authors:  Ammad Ahmad Farooqi; Mohammed Khalid Javeed; Zeeshan Javed; Asma M Riaz; Shahzeray Mukhtar; Sehrish Minhaj; Sana Abbas; Shahzad Bhatti
Journal:  Immunogenetics       Date:  2011-09-20       Impact factor: 2.846

Review 3.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 4.  Emerging concepts for the role of TRP channels in the cardiovascular system.

Authors:  Rudi Vennekens
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

Review 5.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

6.  Role of the ubiquitin system in regulating ion transport.

Authors:  Daniela Rotin; Olivier Staub
Journal:  Pflugers Arch       Date:  2010-10-23       Impact factor: 3.657

Review 7.  Genetic testing for inherited cardiac disease.

Authors:  Arthur A M Wilde; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

Review 8.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 9.  The TRPM4 channel inhibitor 9-phenanthrol.

Authors:  R Guinamard; T Hof; C A Del Negro
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

10.  TRPM4 inhibition promotes angiogenesis after ischemic stroke.

Authors:  Kok Poh Loh; Gandi Ng; Chye Yun Yu; Chee Kong Fhu; Dejie Yu; Rudi Vennekens; Bernd Nilius; Tuck Wah Soong; Ping Liao
Journal:  Pflugers Arch       Date:  2013-09-17       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.